Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11542526
Oncolytic adenoviral vector and methods of use
granted -
US 11541177
Injection spring for aged prefilled syringe and auto injector
granted -
US 11535870
Adeno-associated virus vectors encoding modified G6PC and uses thereof
granted -
US 11534495
Tissue factor-targeted antibody-drug conjugate
granted -
US 11530398
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 11529427
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11529373
Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage
granted -
US 11517648
Nanofiber paste for growth factor delivery and bone regeneration
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11492388
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11491212
Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted -
US 11464737
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 11452782
Liver-specific constructs factor VIII expression cassettes and methods of use thereof
granted -
US 11446397
Gene therapy vectors for treating heart disease
granted -
US 11433097
Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
granted -
US 11434268
Vascular endothelial growth factor antagonists
granted -
US 11420936
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
granted -
US 11413274
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
granted -
US 11406720
Fibroblast growth factor receptor 2-specific peptide reagents and methods
granted -
US 11406690
Adeno-associated virus factor VIII vectors
granted -
US 11390687
Bispecific antibodies against plasma kallikrein and Factor XII
granted -
US 11376273
Modulation of factor 11 expression
granted -
US 11372008
Blood factor monitoring assay and uses thereof
granted